Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 children aged between 2 and 18 years of age in India., The US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 children aged between 2 and 18 years of age in India., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *